Notably, PFKFB3 emerged as the most promising therapeutic target, exhibiting the highest diagnostic value (AUC = 0.805) and showing significant causal relationships with AD through Mendelian randomization analysis. This evidence concerns the gene PFKFB3 and Alzheimer disease.